Back to Search
Start Over
Quiescent Cancer Cells—A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse.
- Source :
- International Journal of Molecular Sciences; Feb2023, Vol. 24 Issue 4, p3762, 17p
- Publication Year :
- 2023
-
Abstract
- Quiescent cancer cells (QCCs) are nonproliferating cells arrested in the G0 phase, characterized by ki67<superscript>low</superscript> and p27<superscript>high</superscript>. QCCs avoid most chemotherapies, and some treatments could further lead to a higher proportion of QCCs in tumors. QCCs are also associated with cancer recurrence since they can re-enter a proliferative state when conditions are favorable. As QCCs lead to drug resistance and tumor recurrence, there is a great need to understand the characteristics of QCCs, decipher the mechanisms that regulate the proliferative–quiescent transition in cancer cells, and develop new strategies to eliminate QCCs residing in solid tumors. In this review, we discussed the mechanisms of QCC-induced drug resistance and tumor recurrence. We also discussed therapeutic strategies to overcome resistance and relapse by targeting QCCs, including (i) identifying reactive quiescent cancer cells and removing them via cell-cycle-dependent anticancer reagents; (ii) modulating the quiescence-to-proliferation switch; and (iii) eliminating QCCs by targeting their unique features. It is believed that the simultaneous co-targeting of proliferating and quiescent cancer cells may ultimately lead to the development of more effective therapeutic strategies for the treatment of solid tumors. [ABSTRACT FROM AUTHOR]
- Subjects :
- DISEASE relapse
CANCER cells
CANCER relapse
DRUG resistance
TUMOR treatment
TUMORS
Subjects
Details
- Language :
- English
- ISSN :
- 16616596
- Volume :
- 24
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- International Journal of Molecular Sciences
- Publication Type :
- Academic Journal
- Accession number :
- 162141346
- Full Text :
- https://doi.org/10.3390/ijms24043762